Abstract: The invention relates to a process for the solid oral pharmaceutical formulation of a pharmaceutically active ingredient such as levetiracetam, comprising a wet granulation of the pharmaceutically active ingredient and simultaneous fluid bed drying such that, as the pharmaceutical blend granulates it is simultaneously dried thus preventing it from becoming a paste. The invention therein thus provides a novel formulation preparation process characterized by a “combined” Granulation and Fluid Bed Drying process step.

Abstract: A continuous system for growing algae, processing it and converting it into electricity, fuel and animal feed. The system utilizes an algae bioreactor which feeds harvested algae to a biomass extraction system which in turn directs a portion of the harvested algae to a microbial generator. The microbial generator converts the algae into electricity, water and nutrients. The biomass extraction system includes a dewatering device and a biomass dryer. The microbial generator in a preferred embodiment is a microbial fuel cell. Dry algae product used for animal feed, fuel, and the like is obtained from the output of the biomass dryer.

Abstract: The invention relates to a process for the solid oral pharmaceutical formulation of a pharmaceutically active ingredient such as levetiracetam, comprising a wet granulation of the pharmaceutically active ingredient and simultaneous fluid bed drying such that, as the pharmaceutical blend granulates it is simultaneously dried thus preventing it from becoming a paste. The invention therein thus provides a novel formulation preparation process characterized by a “combined” Granulation and Fluid Bed Drying process step.

Abstract: The invention relates to methods of treating disease based upon pharmaceutical compositions, and processes for the preparation thereof, comprising zidovudine, or a derivative thereof and lamivudine, or a derivative thereof. The pharmaceutical composition is made by a wet granulation process whereby a binder is added to the zidovudine, or a derivative thereof. and lamivudine, or a derivative thereof, during the wet granulation process.

Abstract: The invention relates to pharmaceutical compositions of cabergoline and to processes for the preparation and methods of use thereof.